Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Discontinue XIGDUO XR, closely monitor blood glucose levels, and provide appropriate alternative therapy for glycemic control
Both are effective
15 813 subjects with T2D already taking oral glucose-lowering medications were randomised to active comparator therapy for 56 weeks with the primary end-point being change from baseline HbA1c
However, consistent dosing and medical supervision are important for safe and effective long-term results
Some specifically enhance growth hormone release, others benefit the body in other ways
US$ 20.24
US$ 23.53
US$ 23.15
US$ 22.01
US$ 22.79
US$ 26.19
US$ 20.40
US$ 28.75
